Cargando…
Prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) in Obese Type Two Diabetes Patients in an Endocrine Clinic
Introduction: Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver diseases that is expected to become the main cause for liver transplantation by 2030.(1) Its prevalence is increasing globally and regionally, and it is set to become the leading cause of chronic liver...
Autores principales: | Shaghouli, Amna Ali, Aranky, Rola M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089170/ http://dx.doi.org/10.1210/jendso/bvab048.070 |
Ejemplares similares
-
Are Obese Patients Evaluated for Non-Alcoholic Fatty Liver Disease in an Endocrinology Outpatient Clinic?
por: Irazusta, Florencia, et al.
Publicado: (2021) -
ODP008 Nonalcoholic Fatty Liver Disease (NAFLD) Impacts Weight Loss after Bariatric Surgery
por: Abu-Rumaileh, Mohammed, et al.
Publicado: (2022) -
MON-592 The Impact of Bariatric Surgery on the Risk of Non-Alcoholic Fatty Liver Disease in Morbidly Obese Patients
por: Borges-Canha, Marta, et al.
Publicado: (2020) -
SAT-LB016 Diabetes and Non-Alcoholic Fatty Liver Disease in Two Patients with ROHHAD Syndrome
por: Sprague, Jennifer, et al.
Publicado: (2019) -
HepatocyteGHR/STAT5b Signaling Protects Against Liver Injury in NAFLD/NASH Mice Models Independent of Steatosis
por: del Río-Moreno, Mercedes, et al.
Publicado: (2021)